Innovative Silicon-Based Sensing Strategy for the Alzheimer’s Disease Detection by Phage Display

: An innovative biosensing strategy for the diagnosis of Alzheimer’s disease (AD) in human sera has been developed. The technology relied on a silicon flat substrate that was functionalized to perform a phage display detection of anti-amyloid beta (Aβ) antibodies, as AD markers, among the pool of IgGs of human sera. The substrate was derivatized with an interface able to bind and orient the IgGs for the detection operated by an engineered selective probe phage. The interface chemistry and its discrimination activity of healthy and AD sera have been fully characterized.